WeVote
Log In

Bill

BW

Bill

SB 1735

SB 1735 - This act creates the "Lori Zena Baker Act". This act establishes the "Sickle Cell Standing Committee" as a subcomittee of the Missouri Genetic Advisory Committee within the Department of Health and Senior Services, with membership as specified in the act. The Director of the Department of Health and Senior Services shall appoint the committee members. The committee shall assess the impact of sickle cell disease on the state and make recommendations to the General Assembly and Governor regarding services and policies to address the state's needs, as described in the act. This act is substantially similar to HB 1483 (2016). SARAH HASKINS

2026 Regular Session Introduced by Barbara Washington

Missouri establishes a standing legislative committee to coordinate sickle cell disease policy, research, and patient services across state agencies.

Second Read and Referred S Progress and Development Committee
0
WeVote Research Nonpartisan
Bill Summary · SB 1735

Legislative bill overview

SB 1735 establishes a permanent standing committee in Missouri focused specifically on sickle cell disease policy and oversight. The committee would coordinate state efforts related to sickle cell prevention, treatment, research, and patient support services. This creates dedicated legislative infrastructure for addressing sickle cell disease, which disproportionately affects Black Americans.

Why is this important

Sickle cell disease causes significant health disparities and requires specialized medical attention, yet often receives limited policy focus compared to other chronic conditions. A dedicated committee could improve coordination between state agencies, healthcare providers, and patients to address gaps in care, screening, and research funding. This structural change signals legislative commitment to addressing a disease that affects approximately 100,000 Americans, with mortality and morbidity concentrated in specific communities.

Potential points of contention

  • Resource allocation: Critics may question whether establishing a new committee is the most efficient use of legislative resources versus funding existing health initiatives
  • Scope limitations: The bill's effectiveness depends on the committee's actual authority and budget; a standing committee without enforcement power may have limited impact
  • Equity framing: Some may debate whether disease-specific committees are the best approach versus broader health equity initiatives addressing multiple disparities simultaneously

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.